| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Islets of Langerhans | 39 | 2024 | 559 | 8.260 |
Why?
|
| Insulin-Secreting Cells | 35 | 2023 | 442 | 6.430 |
Why?
|
| Pancreas | 19 | 2024 | 263 | 3.440 |
Why?
|
| Pancreas, Exocrine | 5 | 2024 | 18 | 2.510 |
Why?
|
| Insulin | 30 | 2023 | 1191 | 2.120 |
Why?
|
| Glucagon-Secreting Cells | 10 | 2019 | 27 | 1.970 |
Why?
|
| Microcirculation | 4 | 2021 | 104 | 1.940 |
Why?
|
| Diabetes Mellitus | 9 | 2024 | 771 | 1.520 |
Why?
|
| Diabetes Mellitus, Type 2 | 15 | 2020 | 1230 | 1.260 |
Why?
|
| Mice | 50 | 2024 | 12525 | 1.120 |
Why?
|
| Animals | 65 | 2024 | 28901 | 0.980 |
Why?
|
| Somatostatin-Secreting Cells | 4 | 2019 | 7 | 0.930 |
Why?
|
| Diabetes Mellitus, Experimental | 9 | 2015 | 201 | 0.900 |
Why?
|
| Immunohistochemistry | 8 | 2019 | 1827 | 0.830 |
Why?
|
| Pancreatic Polypeptide-Secreting Cells | 2 | 2013 | 5 | 0.800 |
Why?
|
| Green Fluorescent Proteins | 12 | 2014 | 314 | 0.780 |
Why?
|
| Mice, Transgenic | 22 | 2021 | 1642 | 0.770 |
Why?
|
| Diabetes Mellitus, Type 1 | 5 | 2016 | 594 | 0.760 |
Why?
|
| Imaging, Three-Dimensional | 4 | 2019 | 631 | 0.730 |
Why?
|
| Cell Count | 4 | 2017 | 202 | 0.720 |
Why?
|
| Image Processing, Computer-Assisted | 7 | 2013 | 1319 | 0.670 |
Why?
|
| Promoter Regions, Genetic | 7 | 2014 | 996 | 0.650 |
Why?
|
| Glucagon | 9 | 2023 | 115 | 0.630 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 2 | 2017 | 124 | 0.620 |
Why?
|
| Absorptiometry, Photon | 1 | 2019 | 110 | 0.560 |
Why?
|
| Gene Expression Regulation | 5 | 2019 | 2059 | 0.560 |
Why?
|
| Microscopy, Confocal | 6 | 2019 | 286 | 0.560 |
Why?
|
| Biological Variation, Individual | 1 | 2017 | 7 | 0.540 |
Why?
|
| Sulfonylurea Compounds | 2 | 2017 | 69 | 0.530 |
Why?
|
| Models, Biological | 7 | 2021 | 1810 | 0.520 |
Why?
|
| Body Mass Index | 2 | 2019 | 816 | 0.490 |
Why?
|
| Humans | 55 | 2024 | 95992 | 0.490 |
Why?
|
| Cell Differentiation | 6 | 2015 | 1662 | 0.450 |
Why?
|
| Embryonic Stem Cells | 3 | 2011 | 87 | 0.440 |
Why?
|
| Hypertriglyceridemia | 1 | 2015 | 72 | 0.430 |
Why?
|
| Metabolome | 1 | 2015 | 63 | 0.430 |
Why?
|
| Regeneration | 3 | 2016 | 160 | 0.420 |
Why?
|
| Glucose Intolerance | 4 | 2017 | 101 | 0.410 |
Why?
|
| Organ Size | 5 | 2017 | 376 | 0.410 |
Why?
|
| Obesity | 3 | 2019 | 1029 | 0.400 |
Why?
|
| Glucose | 7 | 2018 | 702 | 0.400 |
Why?
|
| Female | 34 | 2021 | 49980 | 0.400 |
Why?
|
| Blood Glucose | 9 | 2021 | 873 | 0.390 |
Why?
|
| Islets of Langerhans Transplantation | 5 | 2014 | 247 | 0.380 |
Why?
|
| Microscopy, Fluorescence | 6 | 2012 | 443 | 0.380 |
Why?
|
| Pancreatic Diseases | 2 | 2023 | 59 | 0.380 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2002 | 125 | 0.370 |
Why?
|
| Ferrets | 3 | 2023 | 50 | 0.370 |
Why?
|
| Swine | 4 | 2023 | 607 | 0.360 |
Why?
|
| Insulin Resistance | 6 | 2019 | 381 | 0.360 |
Why?
|
| Oxidative Stress | 1 | 2015 | 473 | 0.360 |
Why?
|
| Gene Expression | 7 | 2015 | 1319 | 0.340 |
Why?
|
| Male | 25 | 2021 | 45792 | 0.330 |
Why?
|
| Proprotein Convertase 1 | 1 | 2010 | 11 | 0.320 |
Why?
|
| Transcription Factors | 5 | 2011 | 1729 | 0.320 |
Why?
|
| Luminescent Measurements | 1 | 2010 | 64 | 0.320 |
Why?
|
| Homeodomain Proteins | 6 | 2015 | 563 | 0.320 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2010 | 60 | 0.310 |
Why?
|
| Cell Proliferation | 3 | 2015 | 1753 | 0.310 |
Why?
|
| Molecular Imaging | 1 | 2010 | 72 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 11 | 2020 | 3483 | 0.300 |
Why?
|
| Inflammation | 1 | 2015 | 1063 | 0.290 |
Why?
|
| Capillaries | 2 | 2020 | 85 | 0.290 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2009 | 80 | 0.290 |
Why?
|
| Hyperglycemia | 3 | 2021 | 181 | 0.280 |
Why?
|
| Endocrine Disruptors | 2 | 2019 | 28 | 0.280 |
Why?
|
| Liver | 4 | 2007 | 1231 | 0.280 |
Why?
|
| Teratoma | 1 | 2008 | 58 | 0.280 |
Why?
|
| Hepatocyte Nuclear Factor 6 | 1 | 2007 | 5 | 0.270 |
Why?
|
| Transgenes | 2 | 2007 | 186 | 0.270 |
Why?
|
| Rabbits | 3 | 2023 | 639 | 0.270 |
Why?
|
| Adult | 17 | 2019 | 28636 | 0.270 |
Why?
|
| Mutation | 4 | 2017 | 4374 | 0.270 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2014 | 677 | 0.260 |
Why?
|
| Calcium | 6 | 2009 | 1205 | 0.260 |
Why?
|
| Models, Theoretical | 4 | 2018 | 504 | 0.250 |
Why?
|
| Trans-Activators | 4 | 2015 | 446 | 0.250 |
Why?
|
| Polycystic Ovary Syndrome | 3 | 2004 | 208 | 0.240 |
Why?
|
| Luminescent Proteins | 2 | 2005 | 145 | 0.240 |
Why?
|
| Mice, Obese | 3 | 2010 | 49 | 0.230 |
Why?
|
| Infarction | 1 | 2005 | 27 | 0.230 |
Why?
|
| Polyethylene Glycols | 2 | 2020 | 376 | 0.220 |
Why?
|
| Polymorphism, Genetic | 4 | 2004 | 832 | 0.220 |
Why?
|
| Young Adult | 5 | 2019 | 7034 | 0.220 |
Why?
|
| Animals, Newborn | 4 | 2011 | 535 | 0.220 |
Why?
|
| RNA, Messenger | 6 | 2015 | 2088 | 0.210 |
Why?
|
| Somatostatin | 2 | 2018 | 58 | 0.210 |
Why?
|
| Pregnancy | 8 | 2019 | 3239 | 0.210 |
Why?
|
| Acinar Cells | 1 | 2024 | 8 | 0.210 |
Why?
|
| Adenosine Triphosphate | 4 | 2006 | 329 | 0.210 |
Why?
|
| Aging | 4 | 2018 | 766 | 0.210 |
Why?
|
| Nerve Tissue Proteins | 4 | 2021 | 516 | 0.210 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2004 | 101 | 0.200 |
Why?
|
| Glucose Tolerance Test | 5 | 2016 | 235 | 0.200 |
Why?
|
| Endocrine System | 1 | 2023 | 16 | 0.200 |
Why?
|
| Mice, Inbred NOD | 3 | 2015 | 215 | 0.200 |
Why?
|
| Apoptosis | 4 | 2008 | 1756 | 0.200 |
Why?
|
| Flow Cytometry | 3 | 2014 | 725 | 0.200 |
Why?
|
| Biosensing Techniques | 1 | 2004 | 81 | 0.200 |
Why?
|
| In Vitro Techniques | 4 | 2021 | 1014 | 0.200 |
Why?
|
| Regional Blood Flow | 1 | 2023 | 197 | 0.190 |
Why?
|
| Endoplasmic Reticulum | 1 | 2004 | 263 | 0.190 |
Why?
|
| Case-Control Studies | 3 | 2017 | 1962 | 0.190 |
Why?
|
| Infant | 4 | 2017 | 3359 | 0.180 |
Why?
|
| Biological Evolution | 1 | 2010 | 1031 | 0.180 |
Why?
|
| Image Enhancement | 1 | 2005 | 565 | 0.180 |
Why?
|
| Mammals | 1 | 2024 | 261 | 0.180 |
Why?
|
| Myocardial Infarction | 1 | 2005 | 436 | 0.180 |
Why?
|
| Embryo, Mammalian | 3 | 2017 | 224 | 0.170 |
Why?
|
| Cytological Techniques | 1 | 2021 | 31 | 0.170 |
Why?
|
| Calcium Signaling | 2 | 2021 | 142 | 0.170 |
Why?
|
| Dynamins | 1 | 2021 | 50 | 0.170 |
Why?
|
| Kidney | 1 | 2005 | 1135 | 0.160 |
Why?
|
| Diagnostic Imaging | 1 | 2004 | 476 | 0.160 |
Why?
|
| Methylmethacrylates | 1 | 2020 | 6 | 0.160 |
Why?
|
| Paper | 1 | 2020 | 12 | 0.160 |
Why?
|
| Up-Regulation | 4 | 2018 | 740 | 0.160 |
Why?
|
| Methacrylates | 1 | 2020 | 9 | 0.160 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2020 | 85 | 0.160 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2014 | 342 | 0.160 |
Why?
|
| Paracrine Communication | 1 | 2019 | 32 | 0.160 |
Why?
|
| Prediabetic State | 2 | 2010 | 42 | 0.150 |
Why?
|
| Toluidines | 1 | 2019 | 18 | 0.150 |
Why?
|
| Genetic Variation | 3 | 2001 | 1424 | 0.150 |
Why?
|
| Cellulose | 1 | 2020 | 59 | 0.150 |
Why?
|
| Endocrine Cells | 1 | 2019 | 3 | 0.150 |
Why?
|
| Printing, Three-Dimensional | 1 | 2020 | 50 | 0.150 |
Why?
|
| Adolescent | 4 | 2019 | 9878 | 0.150 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 2042 | 0.150 |
Why?
|
| Phosphoproteins | 1 | 2000 | 263 | 0.150 |
Why?
|
| Mutation, Missense | 1 | 2001 | 302 | 0.150 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2014 | 182 | 0.150 |
Why?
|
| Computational Biology | 2 | 2015 | 587 | 0.150 |
Why?
|
| Adiposity | 1 | 2019 | 77 | 0.150 |
Why?
|
| Maternal Exposure | 1 | 2019 | 63 | 0.150 |
Why?
|
| Biotin | 2 | 2020 | 46 | 0.150 |
Why?
|
| Cell Division | 2 | 2011 | 701 | 0.140 |
Why?
|
| Metabolic Diseases | 1 | 2019 | 57 | 0.140 |
Why?
|
| Surface-Active Agents | 2 | 2020 | 62 | 0.140 |
Why?
|
| Middle Aged | 7 | 2019 | 28299 | 0.140 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 1999 | 142 | 0.140 |
Why?
|
| Age of Onset | 2 | 2015 | 345 | 0.140 |
Why?
|
| Cystic Fibrosis | 2 | 2018 | 121 | 0.140 |
Why?
|
| Arterioles | 1 | 2018 | 29 | 0.140 |
Why?
|
| Nutrition Surveys | 1 | 2019 | 125 | 0.140 |
Why?
|
| Potassium Channels | 2 | 2005 | 359 | 0.140 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2018 | 48 | 0.140 |
Why?
|
| Phosphatidylcholines | 1 | 2018 | 50 | 0.140 |
Why?
|
| Sodium Compounds | 1 | 2017 | 3 | 0.140 |
Why?
|
| Arsenites | 1 | 2017 | 7 | 0.140 |
Why?
|
| Frozen Sections | 1 | 2018 | 50 | 0.140 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 85 | 0.130 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2018 | 57 | 0.130 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2019 | 176 | 0.130 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 2885 | 0.130 |
Why?
|
| Hemodynamics | 1 | 2021 | 776 | 0.130 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2017 | 12 | 0.130 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 205 | 0.130 |
Why?
|
| Fatty Acids | 1 | 2018 | 152 | 0.130 |
Why?
|
| Gap Junctions | 1 | 2018 | 147 | 0.130 |
Why?
|
| Sulfonamides | 1 | 2019 | 337 | 0.130 |
Why?
|
| Spleen | 3 | 2006 | 419 | 0.130 |
Why?
|
| Autopsy | 1 | 2017 | 127 | 0.120 |
Why?
|
| Models, Animal | 2 | 2010 | 287 | 0.120 |
Why?
|
| Water Pollutants, Chemical | 1 | 2017 | 140 | 0.120 |
Why?
|
| Japan | 4 | 2001 | 313 | 0.120 |
Why?
|
| Aged | 6 | 2019 | 20927 | 0.120 |
Why?
|
| Drug Resistance | 1 | 2017 | 235 | 0.120 |
Why?
|
| Down-Regulation | 2 | 2015 | 526 | 0.120 |
Why?
|
| Cytoprotection | 1 | 2016 | 51 | 0.120 |
Why?
|
| Sex Factors | 1 | 2019 | 1130 | 0.110 |
Why?
|
| Energy Metabolism | 1 | 2017 | 312 | 0.110 |
Why?
|
| TYK2 Kinase | 1 | 2015 | 7 | 0.110 |
Why?
|
| Child, Preschool | 3 | 2017 | 3969 | 0.110 |
Why?
|
| Cardiovirus Infections | 1 | 2015 | 25 | 0.110 |
Why?
|
| Pancreatic Function Tests | 1 | 2015 | 7 | 0.110 |
Why?
|
| Encephalomyocarditis virus | 1 | 2015 | 39 | 0.110 |
Why?
|
| Rats | 7 | 2011 | 4155 | 0.110 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2014 | 32 | 0.110 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2015 | 81 | 0.110 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 2 | 2007 | 30 | 0.110 |
Why?
|
| Pentanoic Acids | 1 | 2014 | 6 | 0.110 |
Why?
|
| Blood Vessels | 2 | 2005 | 91 | 0.110 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2015 | 65 | 0.110 |
Why?
|
| DNA-Binding Proteins | 1 | 2000 | 1267 | 0.110 |
Why?
|
| Organ Specificity | 4 | 2014 | 285 | 0.110 |
Why?
|
| SOX9 Transcription Factor | 1 | 2014 | 28 | 0.110 |
Why?
|
| Cell Line | 6 | 2011 | 2536 | 0.110 |
Why?
|
| Proinsulin | 2 | 2005 | 124 | 0.110 |
Why?
|
| Paired Box Transcription Factors | 1 | 2014 | 50 | 0.110 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 175 | 0.100 |
Why?
|
| Age Factors | 1 | 2019 | 1959 | 0.100 |
Why?
|
| Computer Simulation | 3 | 2018 | 1158 | 0.100 |
Why?
|
| Cell Cycle | 1 | 2016 | 516 | 0.100 |
Why?
|
| Animals, Genetically Modified | 1 | 2014 | 186 | 0.100 |
Why?
|
| Aged, 80 and over | 3 | 2015 | 7224 | 0.100 |
Why?
|
| Biomarkers | 2 | 2017 | 1931 | 0.100 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2011 | 71 | 0.100 |
Why?
|
| Fractals | 1 | 2013 | 42 | 0.100 |
Why?
|
| Morphogenesis | 1 | 2014 | 211 | 0.100 |
Why?
|
| Models, Anatomic | 1 | 2013 | 93 | 0.100 |
Why?
|
| Risk Assessment | 2 | 2019 | 2498 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2015 | 447 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 1 | 2018 | 1425 | 0.090 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 297 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2011 | 36 | 0.080 |
Why?
|
| Calpain | 2 | 2002 | 113 | 0.080 |
Why?
|
| Video Recording | 1 | 2012 | 215 | 0.080 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 83 | 0.080 |
Why?
|
| Gene Frequency | 3 | 2001 | 703 | 0.080 |
Why?
|
| Amino Acid Sequence | 4 | 2002 | 2090 | 0.080 |
Why?
|
| Invertebrates | 1 | 2010 | 36 | 0.080 |
Why?
|
| Basement Membrane | 1 | 2010 | 57 | 0.080 |
Why?
|
| Dissection | 1 | 2010 | 45 | 0.080 |
Why?
|
| Transplantation Tolerance | 1 | 2011 | 143 | 0.080 |
Why?
|
| Proteins | 3 | 2003 | 816 | 0.080 |
Why?
|
| Haplorhini | 1 | 2009 | 81 | 0.080 |
Why?
|
| Developmental Biology | 1 | 2009 | 29 | 0.080 |
Why?
|
| Interferon-gamma | 1 | 2011 | 462 | 0.080 |
Why?
|
| Cell Size | 1 | 2009 | 71 | 0.080 |
Why?
|
| Exons | 3 | 2000 | 454 | 0.070 |
Why?
|
| Vertebrates | 1 | 2010 | 113 | 0.070 |
Why?
|
| Prognosis | 1 | 2017 | 3993 | 0.070 |
Why?
|
| Pancreatic Ducts | 2 | 2005 | 30 | 0.070 |
Why?
|
| Species Specificity | 1 | 2010 | 708 | 0.070 |
Why?
|
| In Situ Hybridization | 4 | 2005 | 312 | 0.070 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2011 | 487 | 0.070 |
Why?
|
| Child | 3 | 2017 | 7621 | 0.070 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2008 | 7 | 0.070 |
Why?
|
| Microscopy, Electron | 1 | 2008 | 488 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2007 | 34 | 0.070 |
Why?
|
| Alleles | 2 | 2002 | 1157 | 0.070 |
Why?
|
| Molecular Sequence Data | 4 | 2000 | 3040 | 0.070 |
Why?
|
| Sweetening Agents | 1 | 2007 | 17 | 0.070 |
Why?
|
| Heterochromatin | 1 | 2007 | 26 | 0.070 |
Why?
|
| Birds | 1 | 2009 | 173 | 0.070 |
Why?
|
| Bone Marrow Cells | 2 | 2005 | 269 | 0.060 |
Why?
|
| X Chromosome | 1 | 2007 | 157 | 0.060 |
Why?
|
| Central Nervous System | 1 | 2007 | 153 | 0.060 |
Why?
|
| Uterus | 2 | 1999 | 228 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2011 | 997 | 0.060 |
Why?
|
| Freund's Adjuvant | 1 | 2006 | 27 | 0.060 |
Why?
|
| Cell Transplantation | 1 | 2006 | 48 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 2534 | 0.060 |
Why?
|
| Bile Ducts | 1 | 2005 | 61 | 0.060 |
Why?
|
| Ischemic Preconditioning | 1 | 2006 | 37 | 0.060 |
Why?
|
| Stochastic Processes | 2 | 2016 | 79 | 0.060 |
Why?
|
| Diabetic Neuropathies | 1 | 2005 | 42 | 0.060 |
Why?
|
| Potassium | 1 | 2006 | 271 | 0.050 |
Why?
|
| Phylogeny | 1 | 2010 | 1277 | 0.050 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2004 | 58 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 564 | 0.050 |
Why?
|
| Reference Values | 2 | 2006 | 675 | 0.050 |
Why?
|
| Intermediate Filament Proteins | 1 | 2003 | 35 | 0.050 |
Why?
|
| Cells, Cultured | 4 | 2011 | 2928 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2021 | 2160 | 0.050 |
Why?
|
| Integrases | 1 | 2003 | 67 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2005 | 1267 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2004 | 930 | 0.050 |
Why?
|
| Introns | 2 | 2000 | 304 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2003 | 289 | 0.050 |
Why?
|
| Dynamin II | 1 | 2021 | 15 | 0.040 |
Why?
|
| Fasting | 1 | 2002 | 165 | 0.040 |
Why?
|
| Hypothyroidism | 1 | 2004 | 276 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2015 | 2474 | 0.040 |
Why?
|
| GTP-Binding Proteins | 1 | 2021 | 148 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2002 | 796 | 0.040 |
Why?
|
| Heterozygote | 1 | 2002 | 383 | 0.040 |
Why?
|
| Endoderm | 2 | 2011 | 25 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2000 | 85 | 0.040 |
Why?
|
| Endocytosis | 1 | 2021 | 186 | 0.040 |
Why?
|
| Family Health | 1 | 2001 | 159 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2017 | 2611 | 0.040 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2000 | 60 | 0.040 |
Why?
|
| Immobilized Nucleic Acids | 1 | 2020 | 2 | 0.040 |
Why?
|
| Chi-Square Distribution | 1 | 2001 | 365 | 0.040 |
Why?
|
| Adipose Tissue | 2 | 2018 | 272 | 0.040 |
Why?
|
| Biotinylation | 1 | 2020 | 42 | 0.040 |
Why?
|
| Graft Rejection | 1 | 2006 | 1127 | 0.040 |
Why?
|
| Aptamers, Nucleotide | 1 | 2020 | 26 | 0.040 |
Why?
|
| Thrombin | 1 | 2020 | 61 | 0.040 |
Why?
|
| Genetic Testing | 2 | 2001 | 566 | 0.040 |
Why?
|
| Corpus Luteum | 1 | 1999 | 14 | 0.040 |
Why?
|
| Sulfonylurea Receptors | 1 | 1999 | 50 | 0.040 |
Why?
|
| Cattle | 1 | 2020 | 401 | 0.040 |
Why?
|
| Receptors, Drug | 1 | 1999 | 52 | 0.040 |
Why?
|
| Membrane Potentials | 2 | 2018 | 442 | 0.040 |
Why?
|
| Cell Lineage | 2 | 2011 | 324 | 0.040 |
Why?
|
| Base Sequence | 2 | 2000 | 2341 | 0.040 |
Why?
|
| Myometrium | 1 | 1999 | 54 | 0.040 |
Why?
|
| Genetic Code | 1 | 1998 | 26 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 1998 | 51 | 0.030 |
Why?
|
| Pancreatic Stellate Cells | 1 | 2018 | 4 | 0.030 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2018 | 11 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2020 | 262 | 0.030 |
Why?
|
| Mice, SCID | 2 | 2011 | 279 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 2018 | 67 | 0.030 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2018 | 29 | 0.030 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2019 | 144 | 0.030 |
Why?
|
| Ovary | 1 | 1999 | 267 | 0.030 |
Why?
|
| Hyperplasia | 1 | 2018 | 149 | 0.030 |
Why?
|
| Secretory Pathway | 1 | 2017 | 23 | 0.030 |
Why?
|
| Cytokines | 2 | 2016 | 871 | 0.030 |
Why?
|
| Placenta | 1 | 1999 | 191 | 0.030 |
Why?
|
| Pregnancy, Animal | 1 | 1997 | 58 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 897 | 0.030 |
Why?
|
| Sexual Maturation | 1 | 2017 | 35 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2019 | 340 | 0.030 |
Why?
|
| Neurons | 1 | 2005 | 1654 | 0.030 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 1996 | 16 | 0.030 |
Why?
|
| Algorithms | 2 | 2015 | 2018 | 0.030 |
Why?
|
| Binding Sites | 1 | 1999 | 1167 | 0.030 |
Why?
|
| Stem Cells | 2 | 2011 | 394 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 1997 | 297 | 0.030 |
Why?
|
| Computer Graphics | 1 | 2016 | 102 | 0.030 |
Why?
|
| Receptors, Purinergic P2 | 1 | 1995 | 16 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 1018 | 0.030 |
Why?
|
| Leptin | 3 | 2004 | 102 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 1996 | 233 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2015 | 297 | 0.030 |
Why?
|
| Carbocyanines | 1 | 2014 | 18 | 0.030 |
Why?
|
| Succinimides | 1 | 2014 | 12 | 0.030 |
Why?
|
| Streptavidin | 1 | 2014 | 14 | 0.030 |
Why?
|
| Tissue Survival | 1 | 2014 | 13 | 0.030 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2014 | 8 | 0.030 |
Why?
|
| Cell Tracking | 1 | 2014 | 14 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2014 | 81 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 1997 | 682 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2015 | 303 | 0.030 |
Why?
|
| Interferon Type I | 1 | 2015 | 171 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 2014 | 156 | 0.030 |
Why?
|
| Cell Communication | 1 | 2014 | 220 | 0.030 |
Why?
|
| Tomography, Optical | 1 | 2013 | 9 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2000 | 3115 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2014 | 430 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2015 | 618 | 0.020 |
Why?
|
| Enzyme-Linked Immunospot Assay | 1 | 2011 | 8 | 0.020 |
Why?
|
| Chromatin | 1 | 2015 | 445 | 0.020 |
Why?
|
| Fibroblast Growth Factor 10 | 1 | 2011 | 7 | 0.020 |
Why?
|
| SOXF Transcription Factors | 1 | 2011 | 10 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 256 | 0.020 |
Why?
|
| Laminin | 1 | 2010 | 92 | 0.020 |
Why?
|
| Kinetics | 2 | 2006 | 1561 | 0.020 |
Why?
|
| Haplotypes | 2 | 2002 | 652 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2011 | 819 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 562 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 2776 | 0.020 |
Why?
|
| Time Factors | 2 | 2008 | 5593 | 0.020 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor Receptors | 1 | 2008 | 2 | 0.020 |
Why?
|
| Thapsigargin | 1 | 2008 | 55 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2008 | 45 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2008 | 23 | 0.020 |
Why?
|
| Chromosome Mapping | 2 | 2000 | 1080 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 367 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2006 | 64 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2008 | 3581 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 2006 | 172 | 0.010 |
Why?
|
| Embolism | 1 | 2006 | 34 | 0.010 |
Why?
|
| Polyploidy | 1 | 2005 | 19 | 0.010 |
Why?
|
| Cell Fusion | 1 | 2005 | 39 | 0.010 |
Why?
|
| Sciatic Nerve | 1 | 2005 | 37 | 0.010 |
Why?
|
| Androstadienes | 1 | 2006 | 74 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2006 | 164 | 0.010 |
Why?
|
| Caspases | 1 | 2006 | 156 | 0.010 |
Why?
|
| Cell Survival | 1 | 2008 | 1029 | 0.010 |
Why?
|
| Ganglia, Spinal | 1 | 2005 | 76 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2006 | 159 | 0.010 |
Why?
|
| Portal Vein | 1 | 2006 | 122 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2008 | 1156 | 0.010 |
Why?
|
| Exocytosis | 1 | 2005 | 110 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 1533 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2006 | 284 | 0.010 |
Why?
|
| Sodium Channels | 1 | 2005 | 131 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2005 | 408 | 0.010 |
Why?
|
| AT Rich Sequence | 1 | 2004 | 7 | 0.010 |
Why?
|
| Body Weight | 1 | 2006 | 460 | 0.010 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2005 | 127 | 0.010 |
Why?
|
| Autoimmunity | 1 | 2006 | 191 | 0.010 |
Why?
|
| Pituitary Diseases | 1 | 2004 | 6 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2005 | 291 | 0.010 |
Why?
|
| Protein Phosphatase 1 | 1 | 2004 | 31 | 0.010 |
Why?
|
| Calcium Channels | 1 | 2005 | 183 | 0.010 |
Why?
|
| Ischemia | 1 | 2006 | 256 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2005 | 197 | 0.010 |
Why?
|
| Nestin | 1 | 2003 | 18 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2003 | 70 | 0.010 |
Why?
|
| Hormones | 1 | 2004 | 144 | 0.010 |
Why?
|
| RNA, Untranslated | 1 | 2003 | 69 | 0.010 |
Why?
|
| Mesoderm | 1 | 2003 | 122 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2005 | 1023 | 0.010 |
Why?
|
| Homeostasis | 1 | 2005 | 466 | 0.010 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2003 | 140 | 0.010 |
Why?
|
| Arteries | 1 | 2003 | 181 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2003 | 242 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2006 | 1741 | 0.010 |
Why?
|
| Pedigree | 1 | 2004 | 978 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 1966 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 2004 | 257 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2003 | 437 | 0.010 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2002 | 125 | 0.010 |
Why?
|
| Finland | 1 | 2000 | 31 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2002 | 686 | 0.010 |
Why?
|
| Mexican Americans | 1 | 2000 | 70 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2000 | 477 | 0.010 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 1998 | 27 | 0.010 |
Why?
|
| Receptors, Leptin | 1 | 1997 | 33 | 0.010 |
Why?
|
| Genotype | 1 | 2002 | 1883 | 0.010 |
Why?
|
| Rats, Zucker | 1 | 1996 | 38 | 0.010 |
Why?
|
| Neuropeptide Y | 1 | 1996 | 31 | 0.010 |
Why?
|
| DNA | 1 | 2002 | 1329 | 0.010 |
Why?
|
| Genome, Human | 1 | 2000 | 823 | 0.010 |
Why?
|
| Insulinoma | 1 | 1995 | 39 | 0.010 |
Why?
|
| Phenotype | 1 | 2002 | 2575 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 1995 | 143 | 0.010 |
Why?
|
| Chickens | 1 | 1995 | 212 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1995 | 422 | 0.010 |
Why?
|
| Oocytes | 1 | 1995 | 227 | 0.010 |
Why?
|
| DNA Primers | 1 | 1995 | 548 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1995 | 648 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 1995 | 402 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 1998 | 750 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1995 | 1046 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1995 | 1006 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1995 | 687 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2004 | 3642 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 1995 | 725 | 0.000 |
Why?
|
| United States | 1 | 2000 | 7785 | 0.000 |
Why?
|